Princeton, NJNCT06870617Now EnrollingIRB Ready

Geriatric Assessment Clinical Trial in Princeton, NJ

Access cutting-edge geriatric assessment treatment through this clinical trial at a research site in Princeton. Study-provided care at no cost to qualified participants.

Sponsored by Abramson Cancer Center at Penn Medicine

Quick Self-Assessment

See if you qualify for this Princeton location

Preparing your pre-screening questions…

Expert Care in Princeton

Access geriatric assessment specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related geriatric assessment treatment provided free

Apply for This Princeton Location

Check if you qualify for this geriatric assessment clinical trial in Princeton, NJ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Princeton

    Convenient for NJ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Princeton site if eligible
  4. 4Begin participation

About This Geriatric Assessment Study in Princeton

The use of a geriatric assessment to inform oncologic care for older persons with cancer is an evidence-based practice that improves patient-clinician communication, reduces treatment-related toxicity, and is recommended by national guidelines. However, the implementation of a geriatric assessment can be time-consuming and burdensome, leading to suboptimal use in clinical practice. Developed and endorsed by the American Society for Clinical Oncology (ASCO), the Practical Geriatric Assessment (PGA) is designed to improve clinical usability and adoption, but its implementation in real-world settings has not been evaluated. The PACE-70 study aims to evaluate PGA implementation and resultant chemotherapy dose modification among older adults with advanced cancer treated in a community setting. An exploratory aim will evaluate how the PGA, body composition (via abdominal computed tomography scan) and step count monitoring (via FitBit) correlate with chemotherapy toxicity and other clinical outcomes.

Sponsor: Abramson Cancer Center at Penn Medicine

Who Can Participate

Inclusion Criteria

. For Correlative Analysis Cohort, patients will be excluded if meeting any of the following criteria:
Unable to effectively read and speak English
Reliance on a wheelchair, ECOG of 3 or above, clinically bedbound, or unable to walk without assistance every day for the past 7 days (ECOG 3 is confined to bed or chair for more than 50% of waking hours)
Concurrent enrollment in a therapeutic clinical trial (as clinical trials often have a substantial symptom-reporting structure). Non-therapeutic clinical trial enrollment is permitted
Lack of clinician consent to approach patient

Exclusion Criteria

other than not meeting inclusion criteria. For Correlative Analysis Cohort, patients will be excluded if meeting any of the following criteria:
Unable to effectively read and speak English
Reliance on a wheelchair, ECOG of 3 or above, clinically bedbound, or unable to walk without assistance every day for the past 7 days (ECOG 3 is confined to bed or chair for more than 50% of waking hours)
Concurrent enrollment in a therapeutic clinical trial (as clinical trials often have a substantial symptom-reporting structure). Non-therapeutic clinical trial enrollment is permitted
Lack of clinician consent to approach patient

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Princeton?

Yes, this clinical trial (NCT06870617) has an active research site in Princeton, NJ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Geriatric Assessment Treatment Options in Princeton, NJ

If you're searching for geriatric assessment treatment options in Princeton, NJ, this clinical trial (NCT06870617) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Princeton research site is actively enrolling participants for this clinical trial. You'll receive care from experienced geriatric assessment specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all geriatric assessment clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Princeton, NJ

See all ankylosing spondylitis clinical trials recruiting in Princeton — not just this study.

Browse Ankylosing Spondylitis Trials in Princeton

Ready to Join in Princeton?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Princeton, NJ